nVerses Capital’s Replimune Group REPL Stock Holding History

nVerses Capital’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,300	Closed	-$14.2K	–	692
2024 Q3	$14.2K	Buy	+1,300	New	+$13.2K	0.01%	851

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

nVerses Capital's REPL Position: Q4 2024 in Review

nVerses Capital sold out of Replimune Group (REPL) in Q4 2024, closing a stake of 1,300 shares — an estimated $14.2K sold.

nVerses Capital first reported a position in REPL in Q3 2024 and held it in 1 quarter. The position peaked at $14.2K in Q3 2024. 157 funds tracked by Wall St. Rank hold REPL as of Q4 2024.

nVerses Capital reported no remaining Replimune Group position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 1,300 Replimune Group shares in Q4 2024, an estimated $14.2K.
nVerses Capital first reported a position in Replimune Group in Q3 2024 and held it in 1 quarter.
nVerses Capital's Replimune Group position peaked at $14.2K in Q3 2024.
157 funds tracked by Wall St. Rank held Replimune Group as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.